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FreeSurferMagnetic resonance imaging measures have been proposed as objective markers to study upper motor
neuron loss in motor neuron disorders. Cross-sectional studies have identiﬁed imaging differences between
groups of healthy controls and patients with amyotrophic lateral sclerosis (ALS) or primary lateral sclerosis
(PLS) that correlate with disease severity, but it is not known whether imaging measures change as disease
progresses. Additionally, whether imaging measures change in a similar fashion with disease progression in
PLS and ALS is unclear. To address these questions, clinical and imaging evaluations were ﬁrst carried out in a
prospective cross-sectional study of 23 ALS and 22 PLS patients with similar motor impairment and 19
age-matched healthy controls. Clinical evaluations consisted of a neurological examination, the ALS Function-
al rating scale-revised, and measures of ﬁnger tapping, gait, and timed speech. Age and ALSFRS score were
not different, but PLS patients had longer duration of symptoms. Imaging measures examined were cortical
thickness, regional brain volumes, and diffusion tensor imaging of the corticospinal tract and callosum. Imag-
ing measures that differed from controls in a cross-sectional vertex-wise analysis were used as regions of in-
terest for longitudinal analysis, which was carried out in 9 of the ALS patients (interval 1.26±0.72 years) and
12 PLS patients (interval 2.08±0.93 years). In the cross-sectional study both groups had areas of cortical
thinning, which was more extensive in motor regions in PLS patients. At follow-up, clinical measures de-
clined more in ALS than PLS patients. Cortical thinning and grey matter volume loss of the precentral gyri
progressed over the follow-up interval. Fractional anisotropy of the corticospinal tracts remained stable,
but the cross-sectional area declined in ALS patients. Changes in clinical measures correlated with changes
in precentral cortical thickness and grey matter volume. The rate of cortical thinning was greater in ALS pa-
tients with shorter disease durations, suggesting that thickness decreases in a non-linear fashion. Thus, cor-
tical thickness changes are a potential imaging marker for disease progression in individual patients, but the
magnitude of change likely depends on disease duration and progression rate. Differences between PLS and
ALS patients in the magnitude of thinning in cross-sectional studies are likely to reﬂect longer disease dura-
tion. We conclude that there is an evolution of structural imaging changes with disease progression in motor
neuron disorders. Some changes, such as diffusion properties of the corticospinal tract, occur early while cor-
tical thinning and volume loss occur later.
© 2012 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-SA license. LSFRS-R, ALS functional rating
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Amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis
(PLS) are clinically distinct motor neuron disorders. Both disorders,
however, are characterized by the progressive dysfunction and loss of
corticospinal, or upper, motor neurons (UMNs). Although clinical signs
are used to diagnose UMNdysfunction, they provide limited information
about the severity of UMN loss. Several types of tests have been proposed
as objective measures of UMN dysfunction (Bowser et al., 2006;
Kaufmann et al., 2004; Turner and Modo, 2010; Ziemann et al., 1997).
Among these, magnetic resonance imaging (MRI) of the brain has re-
ceived themost widespread acceptance as a potential method to quanti-
fy UMN dysfunction (Turner et al., 2011, 2012). Quantitative imaging
methods, including volumetric measures (Tartaglia et al., 2009; Thivard
et al., 2007), diffusion tensor imaging (DTI) (Agosta et al., 2010a; Ellisense. 
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(Mitsumoto et al., 2007; Pyra et al., 2010), and resting state functional
MRI (Agosta et al., 2011, 2012a; Verstraete et al., 2010), showdifferences
between healthy controls and patientswith ALS or PLS. In cross-sectional
studies of ALS patients, some imaging measures correlated with mea-
sures of disease severity. For example, within a group of ALS patients,
the fractional anisotropy (FA) of the corticospinal tract in DTI studies
was correlatedwith scores on the ALS functional rating scale (ALSFRS-R)
and with central motor conduction time (Ellis et al., 1999; Iwata et
al., 2008). From such data it has been suggested that the FA of the
corticospinal tract could serve as a marker of clinical progression.
However, it has not been established that quantitative MRI measures
change with clinical progression in individual patients. Only a small
number of patients have been studied longitudinally; the relationship be-
tween imaging ﬁndings and clinical measures has largely been inferred
from cross-sectional studies. The relationship between FA and clinical
function may be complex. We found that PLS patients had reduced
corticospinal tract FA, but unlike ALS patients in the same study,measures
of corticospinal FA were not correlated with measures of UMN function;
in PLS patients clinicalmeasures correlated betterwith themean diffusiv-
ity (MD) of the corticospinal tract (Iwata et al., 2011). We wondered if
such differences betweenPLS andALS patientswere related to differences
in disease duration or reﬂected differences in their underlying biology. In
ALS, the median survival is 3–5 years from the time of diagnosis
(Czaplinski et al., 2006), whereas the median survival in PLS is often sev-
eral decades long (Floeter and Mills, 2009; Tartaglia et al., 2007).
On the other hand, imaging measures could differ between ALS
and PLS because of differing pathology. A leading hypothesis is that
both disorders lie on the same disease continuumwith a common pa-
thology characterized by neuronal loss and intra-neuronal inclusions,
and that the different clinical phenotypes are caused by regional dif-
ferences in the burden of pathology. Autopsy studies of ALS brains
have found that neuronal inclusions containing TDP-43 extend to
extra-motor cortical regions (Geser et al., 2008). This raises the ques-
tion whether PLS patients have a more restricted phenotype because
of a more restricted distribution of pathology. Because there are few
post-mortem studies of PLS patients, it is difﬁcult to test this hypoth-
esis directly. MRI offers a non-invasive alternative to look for affected
brain regions of living PLS and ALS patients. To date, only a few imag-
ing studies have directly compared cohorts of patients with PLS to pa-
tients with ALS (Ciccarelli et al., 2009; Iwata et al., 2011).
The ﬁrst part of the study addressed the hypothesis that affected re-
gions of the brain differ between PLS and ALS patients, as would be con-
sistent with a differential distribution of pathology. Imaging measures
that potentially could reﬂect pathological changes, such as cortical thick-
ness and volumes of grey and white matter tracts, were assessed in
a cross-sectional study comparing brain MRIs from patients to age-
matched healthy controls. To ﬁrst visualize areas of cortical thinning, an
unbiasedwhole-brain vertex-wise comparisonwas carried out.Measures
of the cortical thickness and grey and white volumes of the regions of in-
terest identiﬁed in that unbiased analysis were then compared between
the patient groups. The second question examined was whether changes
in imaging measures correlated with clinical progression. Approximately
half of the patients in the cross-sectional studywere able to participate in
longitudinal imaging studies. In this subset of patients, we looked at the
correlations between changes in clinical and imaging measures, focusing
on regions of interest identiﬁed in the cross-sectional study and white
matter tracts previously identiﬁed with clinical severity (Agosta et al.,
2010a, 2012b; Ellis et al., 1999; Iwata et al., 2011).
2. Methods
2.1. Subjects
Twenty-two patients who fulﬁlled Pringle's criteria for PLS (Pringle
et al., 1992), 23 patientswith clinical probable or deﬁnite ALS by revisedEl Escorial criteria (Brooks et al., 2000), and 19 age-matched healthy
controls participated in the cross-sectional study. All subjects gavewrit-
ten, informed consent for the protocol, which was approved by the
Institutional Review Board. Some of these patients also participated in
a previously reported diffusion tensor imaging study (Iwata et al.,
2011). A subset of 12 PLS and 9 ALS patients who did not develop con-
traindications to MRI or signiﬁcant respiratory or bulbar dysfunction
had longitudinal clinical evaluations and neuroimaging studies. The in-
terval between scanswas longer for PLS patients than for ALS patients in
order to allow measureable clinical progression between scans.
2.2. Clinical evaluation
A detailed history was obtained to determine the site of onset,
progression of symptoms, and duration of disease. Patients and care-
givers were questioned about behavior that would indicate cognitive
changes or frontotemporal dysfunction. Most patients had neuropsy-
chological testing. None of the patients had frontotemporal dementia
or a family history of ALS or frontotemporal dementia. All ALS and PLS
patients underwent diagnostic testing to conﬁrm that they fulﬁlled
the El Escorial criteria for probable or deﬁnite ALS (Brooks et al.,
2000) or the Pringle criteria for PLS (Pringle et al., 1992). At each
visit, a neurologist performed a neurological examination on all sub-
jects. All healthy controls had normal neurological examinations.
The revised ALS Functional Rating Scale (ALSFRS-R) was recorded
for all subjects (Cedarbaum et al., 1999). Finger tapping speed, time
to walk 20 feet, and time to read a standard passage were measured
to quantify motor function. At the ﬁrst evaluation 4 patients were un-
able to speak, 4 were unable to tap ﬁngers, and 7 patients were un-
able to walk. For statistical analysis, in patients who were unable or
became unable to perform these tasks, a value of zero was imputed
for ﬁnger tapping and a value one second greater than that of the
most severely affected patient was imputed for speech and gait.
Although the true measures of motor function are unknown, this is
a conservative method for imputing values. The rate of disease pro-
gression from onset of symptoms to the ﬁrst study evaluation was
estimated by the following calculation: (48 – ALSFRS-R score at ﬁrst
clinical evaluation)/time in months between ﬁrst symptom and ﬁrst
study evaluation. The rate of disease progression during the follow-
up interval was calculated as follows: (ALSFRS-R score at ﬁrst time
point evaluation – ALSFRS-R score at last time point)/follow-up inter-
val in months.
2.3. Magnetic resonance imaging analysis
Magnetic resonance imaging (MRI) studies were performed on a 3 T
scanner (Philips Achieva, Best, the Netherlands) using a receive-only,
eight-channel SENSE head coil. For volumetric and thickness measure-
ments, a high resolution T1-weighted image was obtained using a
three dimensional turbo ﬁeld echo sequence (3D T1 TFE) with TR=
8.6 ms, TE=3.9 ms, TI=700 ms,ﬂip angle=6°, FOV=240 mm,matrix
size=256×256, slice thickness=1 mm and 140 axial slices. For DTI
studies, multi-slice diffusion weighted imagingwas acquired with diffu-
sionweighting along 32 non-collinear directions (b=1000 s/mm2) and
one volume without diffusion gradients applied (b0). The sequence was
repeated 4 times to increase the signal to noise ratio (TE=86 ms, FOV=
240 mm, matrix size=96×96 reconstructed to 128×128, voxel size=
1.875 mm×1.875 mm×2.5 mm, slice thickness=2.5 mm, and 55 con-
tiguous axial slices aligned parallel to the AC-PC line).
Cortical reconstruction and volumetric segmentation was performed
with the FreeSurfer image analysis suite (http://surfer.nmr.mgh.harvard.
edu/). The technical details of these procedures have been described and
validated in prior publications (Dale et al., 1999; Fischl and Dale, 2000;
Fischl et al., 1999a, 1999b). Brieﬂy, the processing included skull strip-
ping, Talairach transformation, optimization of the grey matter-white
matter and grey matter–CSF boundaries, segmentation, and tessellation
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then inﬂated and registered to a spherical atlas which allowed for
parcellation of the cerebral cortex into units based on gyral and sulcal
structure, and creation of surface based data, includingmaps of curvature
and sulcal depth (Fischl et al., 1999a, 1999b). Cortical thickness was cal-
culated as the closest distance from the grey/white boundary to the grey/
CSF boundary at each vertex on the tessellated surface (Fischl and Dale,
2000). Cortical gyri were parcellated as described by Desikan et al.
(2006) for region-of-interest analyses. To measure changes in cortical
thickness and volume between the initial and follow-up scans, images
were processed using the longitudinal stream in FreeSurfer (http://
surfer.nmr.mgh.harvard.edu/fswiki/LongitudinalProcessing) (Reuter et
al., 2012). Brieﬂy, this processing steam creates an unbiased within-
subject template space and image using a robust inverse consistent reg-
istration (Reuter et al., 2010). Skull stripping, Talairach transformation,
spherical maps, and parcellation are then initialized from the within-
subject template for each subject's time point, utilizing common infor-
mation and thereby increasing reliability and statistical power (Reuter
et al., 2012).
Diffusion tensor imaging, and measurements of diffusion proper-
ties by ﬁber tracking, were carried out using methods previously
described (Danielian et al., 2010; Iwata et al., 2011). Initial image
processing, including eddy current correction, linear registration,
and masking, was performed using FSL (University of Oxford, UK)
(Smith et al., 2004). The diffusion tensor was calculated and ﬁber
tracking was done using DtiStudio (Jiang et al., 2006) (www.MriStudio.
org) using the Fiber Assignment by Continuous Tracking (FACT)method
(Mori et al., 1999; Xue et al., 1999) with a minimum FA value of 0.2 for
tracking termination and maximum 40 degree angle between two adja-
cent eigenvectors. The corticospinal tract (CST)was tracked using amul-
tiple region-of-interest (ROI) approach (Iwata et al., 2011;Wakana et al.,
2007) previously shown to have good reliability for longitudinal studies
(Danielian et al., 2010) and the corpus callosum (CC) was segmented
into the motor ﬁbers of the corpus callosum, genu and splenium
according to the technique of Hofer and Frahm (2006). Whole-tract
measures of mean fractional anisotropy (FA) and mean diffusivity
(MD; 10−3 mm2/s) were calculated within each delineated tract. To as-
sess for changes in cross-sectional area along the rostro-caudal extent of
the corticospinal tract, proﬁles of the mean cross-sectional area within
the tracked CST in each axial slice were constructed as previously de-
scribed (Iwata et al., 2011).
In addition, longitudinal changes in diffusion metrics of the CST in
the same anatomic space were evaluated by an atlas-based method
(Oishi et al., 2009). DTI data was processed with DiffeoMap and
RoiEditor software (Jiang et al., 2006) (www.MriStudio.org). The im-
ageswere normalized to the ICBM-DTI-81 coordinates (Mori et al., 2008)
using 12-mode afﬁne transformation. Subsequently, a non-linear trans-
formation using dual-contrast large deformation diffeomorphic metric
mapping (LDDMM) was applied to register the FA and Trace images
to the 1 mm isotropic resolution template (181×217×181 matrix).
Because both linear and non-linear transformations are reciprocal
procedures, the inversely transformed WMPMI parcellation map
was superimposed onto the original DTI metrics maps from each
patient, leading to the parcellation of the brain into 176 anatomical
structures. For segmentation, a threshold of FAb0.2 and Trace>0.0045
was applied to exclude grey matter and CSF from white matter on the
corresponding images. FA and MD measures were analyzed in ﬁve
anatomically deﬁned regions of the CST parcellated by this atlas-based
method, shown in Fig. 1.
2.4. Statistical analysis
All data in tables are presented as mean±standard deviation.
Basic descriptive statistics and statistical analyses were performed
using SPSS Statistics version 17.0 or SAS version 9.2. For clinical mea-
sures, Box–Cox transformation was applied to timed speech (naturallogarithm), gait measurements (inverse square root) and ALSFRS-R
(square); Shapiro–Wilk was used to test normality (based on the
residuals). Demographic and clinical data were compared between
groups in the cross-sectional study by one-way unequal variance
ANOVA with post hoc Tukey's test. In the longitudinal study, within-
subject changes in clinical measures were determined using a mixed
model, described below.
2.4.1. Cross-sectional imaging analysis
For the cross-sectional study, unbiased whole-brain statistical
comparisons were performed with FreeSurfer's QDEC application
(www.surfer.nmr.mgh.harvard.edu). Surface maps depicting regions
with statistically signiﬁcant differences in cortical thickness at each
vertex across the entire cortical mantle were determined in QDEC
with general linear models (GLMs) using pb0.001 uncorrected as
the threshold for a signiﬁcant cluster. Pairwise comparisons were
made between ALS patients, PLS patients and healthy controls. Age
and gender were not included as covariates in the QDEC model be-
cause these measures did not differ between the groups. Volumes of
grey and white matter regions in which thinning was identiﬁed by
QDEC were compared with a one-way ANOVA with post hoc Tukey's
test.
2.5. Longitudinal analysis
Cortical regions found to have reduced thickness in the cross-
sectional QDEC analysis were used as regions-of-interest in the longi-
tudinal subset. Cortical thickness, grey matter volume and white mat-
ter volume of those regions were assessed, as well as changes in the
FA and MD of the corticospinal tract and mid-posterior portion of
the corpus callosum. The change between the two visits in these im-
aging measures and clinical measures was tested by a mixed model
with patient as random effect. The full model included visits, diagno-
sis, interaction of diagnosis by visit, age and scan interval (p-value of
0.1 used as model selection). For those clinical and imaging measures
showing signiﬁcant change between the two visits, a general linear
model was applied to examine the within-subject correlation, which
described an increase in a clinical measure within the individual
that was associated with an increase (or decrease) in an imaging
measure by removing the difference between subjects (Bland and
Altman, 1995). When an interaction between a clinical measure and
diagnosis was signiﬁcant, the association analysis was applied to
ALS and PLS groups separately.
Brains processed with the FreeSurfer longitudinal stream were
analyzed in QDEC with diagnosis as a discrete factor and disease
duration as the covariate to generate surface maps showing where
rates of thinning (thickness2− thickness1)/(time2−time1) differed
between diagnoses.
3. Results
3.1. Cross-sectional demographics and clinical testing
There were no differences in age or gender between the three
groups in the cross-sectional study (Table 1, left panel). The ALSFRS-R,
timed speech, gait, and ﬁnger tapping rate were signiﬁcantly different
between healthy controls and patients (pb0.001), but did not differ
between the two patient groups. As expected, the mean duration of
disease was longer in the PLS group than in the ALS group and the
rate of disease progression was less in PLS patients than ALS patients.
In the subset of 21 patients who underwent longitudinal studies, the
age and gender ratios were similar to the cross-sectional group, but
there was a trend towards slightly better clinical measures and a slower
initial rate of disease progression in this subset compared to the
cross-sectional group as a whole (Table 1, right panel).
Fig. 1. Regions of the corticospinal tract deﬁned by an atlas-based method that were used for longitudinal analysis of diffusion tensor imaging. Labeled regions include the pons
(CST, blue), cerebral peduncle (Peduncle, turquoise), posterior limb of the internal capsule (PLIC, green), superior corona radiata (SCR, yellow), and the subcortical pre-central
white matter (PreCG, red) (Oishi et al., 2009).
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3.2.1. Group differences in cortical thickness and grey and white matter
volumes
Maps depicting pair-wise regional differences in cortical thickness
between patients and healthy controls are shown in Fig. 2. In PLS pa-
tients cortical thinning was mostly limited to motor regions, with ﬁve
clusters of thinning in the left precentral cortex and two clusters of
thinning in the right precentral cortex (Fig. 2B). The coordinates of
the maxima of the clusters in the precentral region corresponded ap-
proximately to Brodmann area 4 in Talairach space (Table 2) (Fischl
et al., 2008). There was only one very small cluster of thinning outside
of the motor area in PLS, in the left lateral orbital frontal region. In the
ALS patients, clusters of cortical thinning were less extensive than in
PLS patients (Fig. 2A). There were two clusters of cortical thinning in
the left and right motor areas, with coordinates corresponding to
Brodmann areas 4 and 6 in Talairach space (Table 2). Two clusters
of cortical thinning occurred outside motor areas in ALS, in the left
postcentral cortex and a small cluster in the rostral middle frontal
cortex (Table 2). Based on these locations of thinning in the whole-
brain maps, the following seven parcellated regions were selected
for further region-of-interest analyses: right and left precentral
gyrus, right and left paracentral region, left postcentral gyrus, left ros-
tral middle frontal region, and left lateral orbital region.
The total brain, white, and grey matter volumes did not differ be-
tween groups (ANOVA, p>0.2), indicating that there was no global at-
rophy. However, the grey and white matter volumes of some regions ofinterest, normalized for intracranial volume, differed between groups,
suggesting focal atrophy (Supplementary Table 1). The right and left
precentral grey matter volume was reduced in PLS and ALS patients
and the grey matter of the post-central gyrus was reduced in ALS pa-
tients compared to controls. PLS patients also had reduced right and
left precentral and paracentral white matter volume and ALS patients
had reduced volume of the postcentral gyrus white matter.3.3. Longitudinal study
3.3.1. Longitudinal changes in clinical and motor measures
Longitudinal evaluations were carried out in the subset of 9 ALS
patients and 12 PLS patients who did not develop contraindications
to MRI or signiﬁcant respiratory dysfunction. The mean interval
between follow-up evaluations was 1.26±0.72 years for the ALS
patients, and2.08±0.93 years for the PLSpatients. Both groups exhibited
a decline in the ALSFRS-R scores and in several of the motor measures
over the follow-up interval, although the decline was more severe in
the ALS patient group (Table 1, right panel). Mean ALSFRS-R scores de-
clined by approximately 6 points in the ALS patient group and by 3.5
points in the PLS patient group. However, this includes ﬁve PLS patients
who had stable ALSFRS-R scores that dropped one point or less. Measures
of ﬁnger tapping speed declined bilaterally signiﬁcantly in ALS patients
over the follow-up interval. Two ALS patients became unable to perform
one or more of the motor measures at follow-up that were initially
performed. In PLS patients, only left-hand ﬁnger tapping exhibited
Table 1
Characteristics of subjects in cross-sectional study and longitudinal subset.
Cross-sectional study Longitudinal subset
PLS ALS
Control PLS ALS Initial Follow-up Initial Follow-up
Male:Female 11:8 8:14 12:11 7:5 5:4
Age (years) 58.7±5.9 59.0±7.9 55.8±11.3 56.9±9.4 59.41±9.6 57.2±12.6 58.38±13.1
Disease duration (years) a13.5±6.7 3.0±2.5 9.39±4.2 11.87±4.3 3.66±2.9 4.87±3.1
ALSFRS-R b48.0±0.0 36.3±5.2 33.7±7.1 39.8±3.3 c36.2±5.3 40.2±6.3 c34.1±9.8
Speech (s) b51.1±9.0 79.3±26.9 84.3±32.3 78.8±26.0 81.8±26.7 69.4±31.7 85.2±41.8
Gait (s) b4.2±0.7 21.4±24.0 44.9±49.5 12.4±8.0 14.8±11.1 24.9±40.8 54.9±57.1
Finger tapping
R hand (taps/15 s)
b86.7±12.7 48.4±14.0 45.0±32.5 51.0±15.5 48.4±13.3 63.0±31.8 c23.0±28.9
Finger tapping
L hand (taps/15 s)
b85.1±11.6 41.8±14.2 43.4±28.1 46.4±15.0 c41.7±13.00 57.4±29.3 c23.2±29.3
Progression rate⁎ a0.09±0.06 0.77±1.0 0.08±0.04 0.14±0.19 0.59±1.26 0.51±0.58
Follow-up progression rate=(ALSFRS-R1−ALSFRS-R2)/follow-up interval in months.
a PLS and ALS signiﬁcantly different, pb0.05.
b Controls signiﬁcantly different from patients, pb0.001, no difference between PLS and ALS.
c Signiﬁcant longitudinal change, pb0.05.
⁎ Progression rate=(48-ALSFRS-R)/Disease duration in months.
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gait in both groups (ALS p=0.053; PLS p=0.047).3.3.2. Longitudinal changes in diffusion tensor imaging
The corticospinal tract was analyzed both by a ﬁber tracking
method and an atlas-based method. Fiber tracking showed a reduced
mean FA and increased MD of the corticospinal tract compared to
previously reported controls (Iwata et al., 2011), but the mean CST
FA and MD remained relatively stable over the follow-up period, as
illustrated for individual ALS and PLS patients (Supplementary Fig.
1). However, the mean cross-sectional area of the tracked CST became
thinner along its rostro-caudal extent in the ALS patient group be-
tween the initial and follow-up evaluations (Fig. 3A). In PLS patients,
the cross-sectional area of the CST remained stable over time (Fig. 3B).
The atlas-basedmethod likewise found no consistent pattern of change
in the FA andMDmeasurements over the follow-up interval for the ﬁve
regions of the corticospinal tract deﬁned anatomically (Supplementary
Fig. 2). Themid-portion of the corpus callosum,whereﬁbers connecting
the motor cortices travel (Hofer and Frahm, 2006) had lower FA and
higher MD than previously published controls (Iwata et al., 2011), butFig. 2. Areas of cortical thinning identiﬁed in the cross-sectional study by a whole-brain ve
(FreeSurfer QDEC) Regions of thinning compared to healthy controls are shown for (A) ALS
icance of the cluster, ranging from the threshold value of pb0.001 to pb0.00001. White line
indicate the region parcellated as paracentral region. Hemispheres are viewed from left tothe FA and MD remained stable during the follow-up interval in both
patient groups (not shown).3.3.3. Longitudinal changes in cortical thickness
Imagingmeasures from the two timepointswere obtained using the
longitudinal processing stream in FreeSurfer (Reuter et al., 2012) and
analyzed in SAS 9.2. Changes in the mean cortical thickness for each of
the seven regions of interest (Table 2) were evaluated using a mixed
model that included factors of age, scan interval, and diagnosis. PLS
and ALS patients both had signiﬁcant thinning of the right and left
precentral gyrus between the two scans (pb0.001). There was a signif-
icant effect of the scan interval (pb0.005),with a greater degree of thin-
ning when the interval between scans was longer. Signiﬁcant thinning
between scans also occurred in the left postcentral gyrus (p=0.0095)
where thinningwas affected by age (p=0.0194), but not by scan inter-
val. Age did not signiﬁcantly affect the thinning of the other regions
studied.
To assess the effects of disease duration on the rate of thinning in
ALS and PLS patients, a whole-brain vertex-wise analysis was carried
out in QDEC using pb0.001 as the threshold for signiﬁcance. Thertex-wise analysis, shown projected on a smoothed average of all brains in this study.
patients and (B) PLS patients. The color of the scale bar indicates the statistical signif-
s indicate the approximate region parcellated as precentral gyrus and the yellow lines
right as: left lateral, left medial, right medial, right lateral.
Table 2
Size and coordinates of clusters of cortical thinning in patients compared to controls
identiﬁed in cross-sectional study vertex-wise analysis.
Cluster size
(mm2)
Coordinate of maxima
(Talairach coordinates)
FreeSurfer Region
PLSbControls
Left 273.4a −32.8 −16.3 43.9 Precentral
72.6a −50.7 −5.4 41.7 Precentral
23.4a −57.6 2.2 22.3 Precentral
15.3a −25.9 −11.1 50.1 Precentral
8.1a −28.7 −21.4 49.3 Precentral
1.8a −30.5 28.4 −15.2 Lateral orbital frontal
Right 83.2a 5.6 −15.8 68.1 Precentral
54.4a 36.3 −10.8 52.9 Precentral
ALSbControls
Left 64.5 −37.9 −10.3 46.8 Precentral
40.7 −7.5 −21.6 69.0 Paracentral
1.4 −39.9 49.6 −8.8 Rostral middle frontal
84.0 −24.5 −26.9 53.8 Postcentral
Right 38.6 38.6 −9.2 55.5 Precentral
6.1 5.4 −18.4 69.8 Paracentral
ALS>Controls
Right 43.5 18.6 14.2 −19.3 Lateral orbital frontal
Threshold for signiﬁcance was pb0.001 (uncorrected).
a Comparison also signiﬁcant at pb0.05 with FDR correction for multiple comparisons.
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rates of thinning differed between ALS and PLS patients (Fig. 4A).
These areas were located in the left and right precentral gyrus, the
right paracentral region, the right superior frontal region, and the
left cuneus region. For each of the ﬁve areas, the slope of the rate of
thinning versus time from disease onset (using the mid-interval
time point) differed for ALS patients and PLS patients. In ALS patients
the rates of thinning in these areas was greatest in patients with aFig. 3. Longitudinal changes in the cross-sectional area of the corticospinal tract. Dashed
lines indicate the initial scan visit and solid colored lines indicate the follow-up. Fiber track-
ing was used to deﬁne the CST from the level of themid-pons to themotor cortex and the
two sides were averaged for the proﬁles. (A) In ALS patients, the cross-sectional area of the
CST declined between the initial and follow-up evaluation. (B) In PLS patients, the CST
cross-sectional area is smaller than in ALS, but there is no change during the follow-up in-
terval. Dashed lines from left to right indicate three anatomic levels of the corticospinal
tract: peduncle, internal capsule, and subcortical white matter.shorter disease duration, whereas the rates of thinning in PLS patients
were similarly low in patients across the range of disease durations
(Fig. 4B). Thickness of the right and left precentral cortex at each
time point is shown for individual patients in Fig. 5 to further illus-
trate these differences.
3.3.4. Longitudinal changes in volumes of grey and white matter in
regions of interest
In most of the regions with signiﬁcant changes in cortical thick-
ness, there generally was reduced volume of grey and white matter
(Supplementary Table 2). The volume of grey matter declined in
the precentral gyri bilaterally and the left postcentral gyrus in both
ALS and PLS patients. Both groups also had loss of white matter
volume in the left postcentral gyrus. PLS patients had loss of white
matter volume in the precentral gyrus. There was also volume loss
in the midposterior portion of the corpus callosum, adjusted for
age. Age was not a signiﬁcant factor in the volume loss observed in
the other grey and white matter regions.
3.3.5. Correlation between longitudinal changes in clinical and imaging
measures
Correlations were calculated between clinical and imaging mea-
sures that had signiﬁcant declines over the follow-up interval. The
decline in the ALSFRS-R score was correlated with thinning of the
precentral cortex (left r=0.459, p=0.036; right r=0.542, p=0.011),
loss of precentral grey matter volume (left r=0.493, p=0.023;
right r=0.560, p=0.011), loss of left precentral white matter vol-
ume (r=0.569, p=.007), and loss of left postcentral white matter
volume (r=0.628, p=0.002) in ALS and PLS patients. In PLS pa-
tients, the decline in left hand ﬁnger tapping speed was associated
with a decline in right precentral cortex thickness (r=0.586, p=0.036)
and grey matter volume (r=0.644, p=0.0176), with a trend toward an
association with volume of the mid-posterior region of the corpus
callosum (r=0.522, p=0.067). In ALS patients, the decline in right
hand ﬁnger tapping rate was associated with a decline in the white mat-
ter of the postcentral gyrus (r=0.713, p=0.0207).
4. Discussion
There is a longstanding debatewhether primary lateral sclerosis and
amyotrophic lateral sclerosis are variants of the samedisease (Rowland,
1999; Swash et al., 1999). Two characteristics that distinguish PLS from
ALS are long survival and lack of signiﬁcant lower motor neuron signs.
Both disorders, however, have progressive upper motor neuron loss.
In ALS, neuronal loss and pathological inclusions are widespread in
the brain, but it is not known whether the same is true in PLS. The
ﬁrst part of this study compared the distribution of cortical thinning, a
potential imaging marker of pathological change, in ALS and PLS pa-
tients to healthy controls in a whole-brain analysis. In the motor re-
gions, cortical thinning occurred in a similar distribution in ALS and
PLS patients, but themagnitude of thinningwas greater in PLS patients.
In PLS patients, cortical thinning was highly localized to the precentral
gyrus and adjacent paracentral region, with only one very small cluster
in the lateral orbitofrontal cortex. Thinning of the motor cortex is con-
sistent with our earlier report in PLS patients using manual measure-
ments of the precentral gyrus from T1 weighted MRI scans (Butman
and Floeter, 2007), but that study did not examine the whole brain to
look for changes in other regions. The current study did not ﬁnd global
atrophy in PLS patients, in contrast to a prior report (Tartaglia et al.,
2009). However, in regions with large areas of thinning, i.e. the
precentral cortex, the volumes of grey and white matter were less
than in controls, indicating focal atrophy. Our ﬁndings do not sup-
port the hypothesis that cortical pathology is widespread in PLS pa-
tients. Despite their long duration of disease, imaging differences
weremostly restricted to themotor regions in PLS and did not spread
to adjacent cortical regions. Small areas of cortical thinning within
Fig. 4. Differences in rates of cortical thinning as a function of disease duration in PLS and ALS patients in a whole-brain vertex-wise analysis. (A) Regions where the average rate of
change in thickness differs between ALS patients and PLS patients are shown on the smoothed average brain template (FreeSurfer QDEC). The color of the scale bar indicates the
statistical signiﬁcance of the cluster, ranging from the threshold value of pb0.001 to pb0.00001. Hemispheres are viewed from left to right as: left lateral, left medial, right medial,
right lateral. (B) Plots show the relationship between the rate of change in thickness (mm/year) for ALS patients (red squares) and PLS patients (blue circles) and the time of symp-
tom onset (disease duration at the mid-point of the interval between scans). Data from each plot corresponds to the region of signiﬁcance that is circled in the brain image directly
above in (A). ALS patients (red dashed lines) had a faster average rate of thinning for the circled region compared to PLS patients (blue dashed lines). The solid lines show the ﬁtted
slopes for each disease group. Rate of change in thickness (mm/years)=(thickness2−thickness1)/(time2−time1).
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with other studies (Agosta et al., 2012b; Roccatagliata et al., 2009;
Verstraete et al., 2012). Thinning was also seen in the postcentral
gyrus and a small region in the rostral frontal cortex in ALS. In theFig. 5. Longitudinal changes in the mean cortical thickness of the precentral gyrus in
patients with ALS (red squares) and PLS (blue circles). Time is referenced to the onset
of the patient's symptoms. (A) Left precentral gyrus. (B) Right precentral gyrus.precentral cortex and the postcentral gyrus, where clusters of thinning
were largest in ALS, the volume was also reduced. Although thinning
extended beyond the motor cortex in ALS, it was not as widespread as
has been described in other reports (Agosta et al., 2012b; Verstraete
et al., 2012). Although some of the differences between the studies
can be attributed to differences in the statistical models and method
for selecting regions of interest, another contributing factor may be
that none of the ALS patients in the current study had dementia, which
is associated with greater frontotemporal pathology (Strong and Yang,
2011).
The longitudinal portion of the study examined whether imaging
measures change with clinical progression, focusing on the regions
identiﬁed in the cross-sectional study. In the subset of patients who
had longitudinal evaluations, cortical thinning was found to progress
over time. After adjusting for covariates, in both ALS and PLS patients,
only the precentral gyri showed signiﬁcant interval change in thick-
ness. The decline in thickness of the precentral cortex was correlated
with a decline in the ALSFRS-R score. In PLS patients it also correlated
with a decline in ﬁnger tapping speed. Thinning of the precentral cor-
tex progressed at a faster rate in ALS patients than PLS patients, and
within the group of ALS patients, more rapid thinning occurred in
those with a shorter disease duration. In contrast, in PLS patients
the rate of thinning was low and relatively similar across the range
of disease durations. The different rates of thinning could reﬂect differ-
ences in the underlying disease processes in ALS and PLS. However, an-
other interpretation of these data would be that thinning occurs in a
non-linear fashion, with an early rapid phase of decline followed by a
longer, slower phase of thinning, in a similar manner in both ALS and
PLS patients. The detection of signiﬁcant changes in thickness would
therefore depend on the timing of the scans in relation to the disease
duration and the patient's progression rate. Of note, however, is that
patients with slower rates of progression may be over-represented in
longitudinal studies, because they are more likely to tolerate repeat
evaluations and are less likely to drop out than patients who have
rapid progression of disease. This selection bias was true in the current
study, as evidenced by the slower progression rates in the subset of
patients who had follow-up imaging compared the whole group.
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nal changes occurred in cross-sectional area rather than inwhitematter
diffusion properties. In this study,we analyzed the corticospinal tract by
tractography and by an automated image parcellation/atlas-based anal-
ysis. Both methods yielded the same results, that changes in measures
of corticospinal FA and MD did not correlate with changes in clinical
measures. Tractography, or ﬁber tracking, depends on sufﬁcient axonal
integrity to produce directionality of diffusion for reconstructing tracts.
Although ﬁber tracking of the corticospinal tract had high reliability in
longitudinal studies of healthy controls (Danielian et al., 2010), it has
the drawback that in patients with axonal disruption and loss, it can
only assess surviving ﬁbers. The ﬁber tracking method found that
whole-tract measures of corticospinal tract diffusion properties were
stable during the follow-up period in ALS and PLS patients, although
they differed from control values at both time points. In ALS, the
cross-sectional areas of the corticospinal tract declined between scans,
presumably due to axonal loss and dropout of ﬁbers from tracking.
The atlas-basedmethod is complementary to theﬁber trackingmethod,
as it assesses the brain in a structure-by-structure (group of pixels)
basis using a common parcellation map. The method uses large defor-
mation diffeomorphic metric mapping (LDDMM) as the normalization
algorithm. The LDDMM has a high accuracy in matching the shapes of
different brains to a standard atlas. The measurements acquired with
the atlas-based analysis derive directly from the native images of
each individual, reducing the imprecision produced by the imaging
postprocessing. The atlas-based method showed no change in FA and
MD of the corticospinal tract at the follow-up scan. Although the two
methods did not ﬁnd an interval change in diffusion properties, the
patients' CST FA andMD differed from controls, indicating that changes
in diffusion properties of the white matter tracts had already occurred
prior to the time of the ﬁrst scan. This ﬁnding that diffusion properties
remained relatively stable differs from a study that found a decline in
FA in the superior portion of the right corticospinal tract with a
tractography-based region-of-interest analysis which divided each
CST into three portions (Zhang et al., 2011). In that study, the changes
were driven by a subset of patients with left-onset ALS (Zhang et al.,
2011). This region is not well-tracked with our tractography method,
which used a slightly higher FA threshold for truncation of tracking.
Nevertheless, the atlas-based method also did not ﬁnd changes in
these regions. It is possible that themethodswe usedwere not sensitive
to small changes, particularly given the small sample size in the longitu-
dinal study. Another possibility is that changes in CST diffusion proper-
ties occur very early in ALS, and thus were captured in the study by
Zhang et al. (2011) where the mean disease duration of the group
was 20.8 months, but not in our study where ALS patients had a mean
disease duration of 36.6 months at the time of the ﬁrst scan.
The tissue changes that give rise to imaging changes such as cortical
thinning result from a remodeling process that requires time. In addi-
tion to shrinkage and loss of cortical neurons that could contribute to
cortical thinning (Hudson et al., 1993; Kiernan and Hudson, 1991,
1993), there are also inﬂammatory changes with T-cell inﬁltration
(Henkel et al., 2009), reactive astrocytosis (Murayama et al., 1991;
Vargas and Johnson, 2010), microglia invasion (Turner et al., 2004),
and iron accumulation (Kwan et al., 2012) in the cortex. Thesemay con-
tribute to a gradual thinning that continues beyond the period of neuro-
nal loss, by clearing of necrotic debris and bymaturation of glial scarring
in patients who survive longer. This sequence of changes, and the time
required for them to occur, would be consistent with the greater extent
and degree of thinning of the motor cortex in PLS patients compared to
ALS patients. A similar evolution of tissue changes in the white matter
could also explainﬁndings fromdiffusion tensor imaging studies. Nearly
all cross-sectional diffusion tensor imaging studies have reported
reduced fractional anisotropy of the corticospinal tract in ALS and PLS
patients compared to healthy controls, andmany studies found a corre-
lation between the CST FA and clinical severity scores or progression
rates (Ciccarelli et al., 2006, 2009; Ellis et al., 1999; Iwata et al., 2008,2011; Mitsumoto et al., 2007; Sage et al., 2007; Ulug et al., 2004;
Unrath et al., 2010). In the few longitudinal studies in ALS, lower
corticospinal tract FA correlated with faster rates of disease progres-
sion or shorter survival, where ALS patients were followed for one
(Nickerson et al., 2009) or up to approximately 3.5 years (Agosta et
al., 2010b). The relatively short follow-up periods that can be achieved
with ALS patients may not be sufﬁcient to observe the full evolution of
white matter changes that are seen in PLS patients, some of whom
have decades-long disease durations. The changes in fractional anisot-
ropy may be a relatively early event in motor neuron degeneration,
during active degeneration of corticospinal axons, with loss of cross-
sectional area of the tract occurring afterward. Others have also noted
that diffusion properties can change independently of volumetric
changes (Canu et al., 2011).
Several cross-sectional studies have reported differences in diffu-
sion properties in motor ﬁbers of the corpus callosum in ALS and
PLS compared to healthy controls (Ciccarelli et al., 2009; Douaud et
al., 2011; Iwata et al., 2011). It has been suggested that reduced frac-
tional anisotropy in the mid-posterior corpus callosum is speciﬁc for
ALS, and may precede the onset of clinical signs of upper motor neu-
ron dysfunction (Filippini et al., 2010; Sach et al., 2004). This study
conﬁrms and extends that proposal, ﬁnding that the diffusion proper-
ties of the callosal motor ﬁbers remained stable over the follow-up in-
terval, although volume loss occurred. Thus the sequence of imaging
changes in callosal ﬁbers in motor neuron disease is similar to the
corticospinal tract, with early changes in diffusion properties and
later changes in volume.
This study's ﬁnding that progressive thinning and volume loss oc-
curs primarily the precentral cortex is consistent with a longitudinal
morphometry study that showed atrophy of the precentral region
over a 9-month span in ALS patients (Agosta et al., 2009), but differs
from a recent longitudinal study of ALS patients that found progres-
sive thinning of extra-motor regions over a 3–10 month follow-up
interval (Verstraete et al., 2012). One of the limitations of our longitu-
dinal study is that the small sample sizes limited the number of
regions that could be assessed in our statistical model. Regions of in-
terest were selected from areas identiﬁed in the cross-sectional
model which differed from age-matched controls, and did not include
the whole brain. Of the three extra-motor regions assessed in our lon-
gitudinal model, only the postcentral gyrus showed progressive thin-
ning in ALS patients. Several studies have reported more widespread
atrophy in motor neuron disease (Grosskreutz et al., 2006; Tartaglia
et al., 2009; Turner et al., 2007), including volume loss in the frontal
and temporal lobes in patients with cognitive impairment (Chang et
al., 2005; Strong et al., 2003). In our cross-sectional whole-brain anal-
ysis, a small cluster of thinning was seen in the lateral orbital frontal
cortex in PLS patients, and small cluster of thinning occurred in the
frontal cortex in ALS patients. The lack of more extensive ﬁndings in
extramotor areas may reﬂect better cognitive function, as there is a
selection bias in our study for patients who were able to travel to par-
ticipate in research, compared to a more population-based cohort
such as from a regional clinic (Grace et al., 2011; Murphy et al., 2008).
5. Conclusion
The ﬁndings from this longitudinal study favor the idea that there is
a temporal evolution of imaging changes in the brain in motor neuron
disorders as upper motor neuron degeneration progresses. We propose
that alterations in the diffusion properties of the corticospinal tract and
motor region of the corpus callosum are among the early changes,
which eventually reach a nadir. Cortical thickness declines at a rapid
rate initially, then at a slower rate, with progressive atrophy of the af-
fected grey andwhitematter regions.Within this framework, longitudi-
nal changes in imagingmeasureswill be dependent on disease duration
and progression rate and differences between ALS and PLS patientsmay
be explained by differences in disease duration. Future studies with
159J.Y. Kwan et al. / NeuroImage: Clinical 2 (2013) 151–160larger sample sizes and additional longitudinal evaluations will be
needed to test this proposed sequence of imaging changes. In the
cross-sectional portion of this study, we found small differences be-
tween PLS and ALS patients in the distribution of cortical thinning, not
a substantial differential distribution of pathology. However, this con-
clusion is limited by the clinical similarity of the two patient groups,
with less widespread pathology in the ALS group than reported in
other studies. A more diverse ALS patient sample should be studied to
better assess regional differences between PLS and ALS. Lastly, we con-
clude that the imaging measure that best correlates with clinical pro-
gression is the decline in cortical thickness of the precentral gyrus.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.nicl.2012.12.003.
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